Elizabeth McGowan & Outpedaling 'The Big C'

By Cody R. Barnett, MRA Director of Communications | 18 September 2020 In Melanoma Stories

To celebrate her fifth anniversary of being NED, Elizabeth McGowan set out on a 4,250- mile adventure across the United States, coined 'Heals on Wheels.' Now, 20-years later, the Pulitzer Prize-winning author shares insight into her journey with melanoma and her solo bicycle trek in her book: "Outpedaling ‘The Big C’: My Healing Cycle Across America."

Read More


Integrative Medicine Answers the Question: ‘What Can I Do to Support My Treatment?’

By Cody R. Barnett, MRA Director of Communications | 24 August 2020 In Science, Treatment

When Dr. Gary Deng sits down with a new patient to discuss their goals and how integrative medicine can fit into their overall treatment plan, he likens his work to taking care of a plant. “With the right amount of water, sunshine, fertilizer, and soil – a plant will thrive. That’s what integrative medicine is looking to do, but with an entire person,” says Deng.

Read More


Working to Take the Luck Out of Melanoma

By Cody R. Barnett, MRA Director of Communications | 16 August 2020 In Melanoma Stories

Ellen believes that research is the best tool we have to “take the luck” out of melanoma. She’s proud to be involved with an organization – and a cause – that is relentlessly moving forward in search of answers, new treatments, and ultimately a cure for melanoma. “I know that given the right support, research will get us there,” she says.

Read More


Expanding the Tool Box: New Melanoma Treatment Approaches Being Explored

29 July 2020 In Science, Treatment

Despite the tremendous progress made in melanoma treatments over the last 10 years, only about half of such patients respond favorably to current treatments. During the MRA’s Melanoma > Exchange Patient & Advocate Forum, MRA-funded investigators shared updates on emerging science and promising clinical trials.

Read More


For Melanoma Researcher Dr. Betina Yanez, It’s All About the Journey

By Cody R. Barnett, MRA Director of Communications | 27 July 2020 In Science

If you close your eyes and imagine what a melanoma researcher looks like, Dr. Betina Yanez is probably not what you imagine. That’s because Dr. Yanez, a health psychologist by training, isn’t your typical melanoma researcher. Instead of researching new treatment targets or experimental combination therapies, she focuses on patient experience and quality of life.

Read More


Putting Her Faith in Research & Her Doctor

By Cody R. Barnett, MRA Director of Communications | 23 July 2020 In Melanoma Stories, Treatment

All things considered, things are looking up for Margaret Oplinger. A marble-sized tumor is all that’s left of her Stage 4 melanoma; and her ongoing treatment, every-other week with nivolumab (Opdivo®), will hopefully enable her immune system to attack – and eliminate – this last remnant.

Read More


Basic Research: Understanding what Triggers Melanoma and its Spread to Identify New Treatment Targets

9 July 2020 In Science

Tremendous progress has been made in understanding the basic biology needed to trigger melanoma and fuel its growth and progression. Researchers continue to probe deeper, finding new molecular culprits that could lead to novel and more effective melanoma treatment strategies. Some of these new potential drug targets were revealed at MRA’s 2020 Scientific Retreat.

Read More


Melanoma Research Updates from 2020 AACR and ASCO Conferences

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 29 June 2020 In News, Science, Treatment

MRA Chief Science Officer Marc Hurlbert shares exciting melanoma research highlights from ASCO and AACR - the two largest global cancer research conferences that take place annually.

Read More


Painting a Portrait of the Melanoma Clinical Trial Participant

By Cody R. Barnett, MRA Director of Communications | 26 June 2020 In Allies & Partnerships

MRA Chief Science Officer Marc Hurlbert, MRA Director of Communications Cody Barnett, and Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards discuss what matters most to melanoma patients when it comes to participating in clinical trials.

Read More


A Personal Journey, A Virtual Platform

23 June 2020 In Melanoma Stories, Prevention, Science

Meet Shirin Bajaj, a third-year resident at NYU’s School of Medicine and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Login

×